Nanopac Innovation Limited
| ACN or ARBN: | 169 020 580 |
| NSX Code: | NNO |
| NSX Listed Securities: |
NNO - Nanopac Innovation Limited - CDI |
| Listing Date: | Wednesday, July 23, 2014 |
| Principal Activities: | Nanotechnology |
| Industry Class: | Health Care |
| Street Address: |
31 Highgate Cct Kellyville - NSW Australia 2155 |
| Company Base: | Malaysia |
| Web: |
www.nanopac.com.my/ |
| Email: |
info@nanopac.com.my |
| Phone: | 603-8070 7428 |
| Fax: | 603-8076 6487 |
| Chairman: | Dato Dr. Cheng Kok Leong |
| Directors: | Dr. Cheng K Leong Nazrulshah Bin Md Yusop Cheang Soon Siang |
| Company Secretary: | Andrew Bristow |
| Nominated Advisers: | Dash Corporate Lawyers Pty Ltd |
| Auditor: | ESV Business Advise and Accounting Level 13, 68 York Street Sydney NSW 2000 Tel: +61 2 9283 1666 Em: admin@esvgroup.com.au |
| Share Registry: | Boardroom Pty Limited Level 8 210 George Street Sydney NSW 2000 GPO Box 3993 Sydney NSW 2001 Phone: 1300 737 760 (Australia) +61 2 9290 9600 (International) Fax: 1300 653 459 (Australia) +61 2 9279 0664 (International) |
| Other Trading Exchanges: | Frankfurt (Code NNPA) |
| Balance Date: | 31-Dec |